Catalyst Wire Dossier Catalyst Wire Dossier

CIMZIA

CERTOLIZUMAB PEGOL · UCB, Inc.
Drug timelines are a Plus or Pro feature.

84 regulatory and trial events tracked for CIMZIA, covering 2008-03-20 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]

See pricing